Long-term effects of incident diabetes mellitus on cardiovascular outcomes in people treated for hyper- tension: the ALLHAT Diabetes Extension Study. Circ Cardiovasc Qual Outcomes. 2012;5:153 162. 101. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure: the SOLVD Investigators. N Engl J Med. 1991;325:293 302. 102. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions: the SOLVD Investigators. N Engl J Med. 1992;327:685 691. 103. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin- converting-enzyme inhibition on diabetic nephropathy: the Collaborative Study Group. N Engl J Med. 1993;329:1456 1462. 104. PROGRESS Collaborative Group. Randomised trial of a perin- dopril-based blood-pressure-lowering regimen among 6,105 indi- viduals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033 1041. 105. Svensson P, de Faire U, Sleight P, Yusuf S, Ostergren J. Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE substudy. Hypertension. 2001;38:E28 E32. 106. Braunwald E, Domanski MJ, Fowler SE, Geller NL, Gersh BJ, Hsia J, Pfeffer MA, Rice MM, Rosenberg YD, Rouleau JL; PEACE Trial Investigators. Angiotensin-converting-enzyme inhibition in stable coro- nary artery disease. N Engl J Med. 2004;351:2058 2068. 107. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L, Hua T, Laragh J, McInnes GT, Mitchell L, Plat F, Schork A, Smith B, Zanchetti A; VALUE Trial Group. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or am- lodipine: the VALUE randomised trial. Lancet. 2004;363:2022 2031. 108. Sica DA. The Valsartan Antihypertensive Long-Term Use Evaluation trial: a study in contrasts. Hypertension. 2006;48:362 363. 109. Dickstein K, Kjekshus J; OPTIMAAL Steering Committee of the OPTIMAAL Study Group. 